These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19115383)

  • 21. Increased Expression of 15-Hydroxyprostaglandin Dehydrogenase in Spinal Astrocytes During Disease Progression in a Model of Amyotrophic Lateral Sclerosis.
    Miyagishi H; Kosuge Y; Takano A; Endo M; Nango H; Yamagata-Murayama S; Hirose D; Kano R; Tanaka Y; Ishige K; Ito Y
    Cell Mol Neurobiol; 2017 Apr; 37(3):445-452. PubMed ID: 27140190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse.
    Fujita K; Yamauchi M; Matsui T; Titani K; Takahashi H; Kato T; Isomura G; Ando M; Nagata Y
    Brain Res; 1998 Feb; 785(1):31-40. PubMed ID: 9526038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heme oxygenase in the experimental ALS mouse.
    Dwyer BE; Lu SY; Nishimura RN
    Exp Neurol; 1998 Apr; 150(2):206-12. PubMed ID: 9527889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Lee JY; Lee JD; Phipps S; Noakes PG; Woodruff TM
    J Neuroinflammation; 2015 May; 12():90. PubMed ID: 25962427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1.
    Warita H; Manabe Y; Murakami T; Shiote M; Shiro Y; Hayashi T; Nagano I; Shoji M; Abe K
    Neurol Res; 2002 Sep; 24(6):577-81. PubMed ID: 12238624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-derived olfactory mucosa for study of the non-neuronal contribution to amyotrophic lateral sclerosis pathology.
    García-Escudero V; Rosales M; Muñoz JL; Scola E; Medina J; Khalique H; Garaulet G; Rodriguez A; Lim F
    J Cell Mol Med; 2015 Jun; 19(6):1284-95. PubMed ID: 25807871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in AQP4 expression and polarization in the course of motor neuron degeneration in SOD1G93A mice.
    Dai J; Lin W; Zheng M; Liu Q; He B; Luo C; Lu X; Pei Z; Su H; Yao X
    Mol Med Rep; 2017 Aug; 16(2):1739-1746. PubMed ID: 28627708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis.
    Lee J; Kannagi M; Ferrante RJ; Kowall NW; Ryu H
    FASEB J; 2009 Jun; 23(6):1739-49. PubMed ID: 19179380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of labile zinc in neurons and astrocytes in the spinal cords of G93A SOD-1 transgenic mice.
    Kim J; Kim TY; Hwang JJ; Lee JY; Shin JH; Gwag BJ; Koh JY
    Neurobiol Dis; 2009 May; 34(2):221-9. PubMed ID: 19344646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model.
    Cui Y; Masaki K; Yamasaki R; Imamura S; Suzuki SO; Hayashi S; Sato S; Nagara Y; Kawamura MF; Kira J
    J Neuroinflammation; 2014 Mar; 11():42. PubMed ID: 24597481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis.
    Sone J; Niwa J; Kawai K; Ishigaki S; Yamada S; Adachi H; Katsuno M; Tanaka F; Doyu M; Sobue G
    J Neurosci Res; 2010 Jan; 88(1):123-35. PubMed ID: 19610091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis.
    Watanabe-Matsumoto S; Moriwaki Y; Okuda T; Ohara S; Yamanaka K; Abe Y; Yasui M; Misawa H
    Neurosci Res; 2018 Aug; 133():48-57. PubMed ID: 29154923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis.
    Cassina P; Pehar M; Vargas MR; Castellanos R; Barbeito AG; Estévez AG; Thompson JA; Beckman JS; Barbeito L
    J Neurochem; 2005 Apr; 93(1):38-46. PubMed ID: 15773903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarm1 knockout modifies biomarkers of neurodegeneration and spinal cord circuitry but not disease progression in the mSOD1
    Collins JM; Atkinson RAK; Matthews LM; Murray IC; Perry SE; King AE
    Neurobiol Dis; 2022 Oct; 172():105821. PubMed ID: 35863521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.